Last update:

Clinical pharmacology news

Rethinking oral cancer treatment: A review of next-generation drug delivery systems

A new review by a team of researchers from Indonesia, Japan and China, led by Professor Nurhasni Hasan from the Faculty of Pharmacy at Hasanuddin University in Indonesia, examines how emerging local drug delivery systems ...

Since the 21st Century Cures Act passed, FDA approvals have relied on fewer studies

Since the passage of the 21st Century Cures Act in 2016, Food and Drug Administration (FDA) approvals for new medical products have relied on fewer studies, according to a study published Aug. 26, 2026, in the PLOS ONE by ...

New mRNA immunotherapy eliminates pancreatic tumors in mice

Inspired by the work of the RNA Therapeutics Institute at UMass Chan Medical School and the development of the COVID vaccine, Marcus Ruscetti, Ph.D., and Chaitanya Naimesh Parikh, Ph.D. '26, have developed an immunotherapy ...

Study suggests new antibody therapy for tick-borne disease

Crimean-Congo hemorrhagic fever virus (CCHFV) is a dangerous virus spread by ticks. It transmits Crimean-Congo hemorrhagic fever (CCHF), a serious disease that has been spreading into new regions worldwide. Capable of killing ...

The lightbulb moment behind a potential antiviral breakthrough

An unexpected observation by a University of Queensland researcher could lead to a new treatment for deadly infectious diseases including COVID‑19, pneumonia in infants and children, or viral infections caused by Ebola and ...

US panel endorses more unproven if buzzy peptides

A U.S. review panel on Friday recommended loosening restrictions on all but one of a buzzy class of peptides, dismissing protests from medical experts who say none are well studied enough to justify wide access.